Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis

Published:2021-02-23 Issue:1 Volume:12 Page:
ISSN:2150-7511
Container-title:mBio
language:en
Short-container-title:mBio

Author:

Ng Wern Hann¹^ORCID,Tipih Thomas²^ORCID,Makoah Nigel A.²^ORCID,Vermeulen Jan-G²^ORCID,Goedhals Dominique²³^ORCID,Sempa Joseph B.⁴⁵^ORCID,Burt Felicity J.²³^ORCID,Taylor Adam¹^ORCID,Mahalingam Suresh¹^ORCID

Affiliation:

1. Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, Southport, QLD, Australia

2. Division of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa

3. Division of Virology, National Health Laboratory Service, Bloemfontein, South Africa

4. Department of Biostatistics, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa

5. DST-NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa

Abstract

COVID-19 has plagued the world since it was first identified in December 2019. Previous systematic reviews and meta-analysis were limited by various factors such as the usage of non-peer reviewed data and were also limited by the lack of clinical data on a global scale.

Funder

Department of Health, Australian Government | National Health and Medical Research Council

Publisher

American Society for Microbiology

Subject

Virology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/mBio.03647-20

Reference104 articles.

1. The structure and functions of coronavirus genomic 3′ and 5′ ends

2. Coronavirus Pathogenesis

3. Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome